ȸ¿ø°¡ÀÔ | ¿¬¶ôó | »çÀÌÆ®¸Ê | English

      È¸»ç¼Ò°³ | ¸®Æ÷Æ® | Ä¿½ºÅÒ ¸®¼­Ä¡ | °í°´Áö¿ø
¿¤¾Ø¿¡Ä¡


·Î±×ÀÎ

Ä«Å×°í¸®

À¯/¹«¼±Åë½Å

Àü±â/ÀüÀÚ

µðÁöÅбâ±â/¹Ìµð¾î/¹æ¼Û

Information Technology

¿¡³ÊÁö

»ý¸í°øÇÐ

È­ÇÐ/½Å¼ÒÀç

ÀÚµ¿Â÷

ȯ°æ

ÀϹݼҺñÀç

¸¶ÄÉÆÃ/±¤°í

±ÝÀ¶

°Ç¼³

±³Åë/¿î¼Û

¼ÒºñÀÚÁ¶»ç

¹æÀ§/Ç×°ø/¿ìÁÖ

½ÄÀ½·á

Áß°ø¾÷

±³À°

±â°è

¹«¿ª

½ºÆ÷Ã÷/·¹Àú

ÇØ¿î/Á¶¼±

ÆмÇ

Á¤ºÎ/Á¤Ã¥

°ø¿¹/±Í±Ý¼Ó

ÄÄÆÛ´Ï ÇÁ·ÎÆÄÀÏ

±âŸ»ê¾÷

 
ÇöÀçÀ§Ä¡ : HOME > ¸®Æ÷Æ® > Á¤º¸Á¦°ø¾÷ü
Á¤º¸Á¦°ø¾÷ü : GBI Research

ÀμâÇÏ±â  
¸®Æ÷Æ® Á¦¸ñ ¹ßÇàÀÏ ¹ßÇà»ç °¡°Ý

Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future

2015³â 12¿ù GBI Research $2,995

Frontier Pharma: Duchenne Muscular Dystrophy and Becker Muscular Dystrophy - Identifying and Commercializing First-in-Class Innovation

2015³â 05¿ù GBI Research $6,995

Frontier Pharma: Asthma - Identifying and Commercializing First-in-Class Innovation

2015³â 05¿ù GBI Research $6,995

MRI Systems Market to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies

2015³â 04¿ù GBI Research $3,500

Frontier Pharma: Parkinson¡¯s Disease - Identifying and Commercializing First-in-Class Innovation

2014³â 11¿ù GBI Research $6,995

Frontier Pharma: Prostate Cancer - Identifying and Commercializing First-in-Class Innovation

2014³â 11¿ù GBI Research $6,995

Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth

2014³â 11¿ù GBI Research $4,995

Market Snapshot: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Asia-Pacific

2014³â 11¿ù GBI Research $1,750

Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options

2014³â 10¿ù GBI Research $4,995

Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries

2014³â 10¿ù GBI Research $4,995

Frontier Pharma: Non-Small Cell Lung Cancer - Identifying and Commercializing First-in-Class Innovation

2014³â 10¿ù GBI Research $6,995

Market Snapshot: Cardiac Rhythm Management Devices 2006 to 2020 - US and Europe (US, Germany, France, Italy, UK, Spain)

2014³â 10¿ù GBI Research $1,750

Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting

2014³â 09¿ù GBI Research $4,995

Market Snapshot: Mammography Systems 2006 to 2020 - Americas (US, Canada, Brazil, Mexico)

2014³â 09¿ù GBI Research $1,750

Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market

2014³â 07¿ù GBI Research $4,995

Market Snapshot: Transcatheter Heart Valves 2007 to 2020 - Americas (US, Canada, Brazil, Mexico)

2014³â 07¿ù GBI Research $1,750

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

2014³â 07¿ù GBI Research $4,995

Market Snapshot: Mammography Systems 2006 to 2020 - Europe (Germany, UK, France, Italy, Spain)

2014³â 07¿ù GBI Research $1,750

Market Snapshot: Mammography Systems 2006 to 2020 - Asia-Pacific (China, Japan, South Korea, Australia and India)

2014³â 06¿ù GBI Research $1,750

Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries

2014³â 06¿ù GBI Research $4,995

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

2014³â 06¿ù GBI Research $4,995

Frontier Pharma: Psoriasis - Identifying and Commercializing First-in-Class Innovation

2014³â 05¿ù GBI Research $6,995

Facial Aesthetics Market to 2020 - Economic Recovery Drives Growth in the US as Increasing Awareness Fuels Demand in Developing Markets

2014³â 05¿ù GBI Research $3,500

Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options

2014³â 05¿ù GBI Research $4,995

Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies

2014³â 05¿ù GBI Research $4,995
  1    2    3    4    5    6    7    8    9    10   

ȸ»ç¼Ò°³ | °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ | ÀÌ¿ë¾à°ü | ¹è¼Û/°áÁ¦¾È³» | ÀÌ¿ë¾È³»

¼­¿ï½Ã °­³²±¸ ³íÇöµ¿ 210-1 »ï¿øºôµù | ȸ»ç¸í : (ÁÖ)¿¤¾Ø¿¡Ä¡
´ëÇ¥ÀüÈ­ : 02-554-0001 / Æѽº : 02-3444-5501 / À̸ÞÀÏ : sales@landh.co.kr
Copyright ¨Ï 2008 LNH, Inc. All rights reserved.